Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

SAVA – Cassava Sciences, Inc.

Cassava Sciences, Inc.
SAVA
$2.12
Name : Cassava Sciences, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $102,412,744.00
EPSttm : -1.59
finviz dynamic chart for SAVA
Cassava Sciences, Inc.
$2.12
0.95%
$0.02

Float Short %

14.96

Margin Of Safety %

Put/Call OI Ratio

0.12

EPS Next Q Diff

EPS Last/This Y

0.53

EPS This/Next Y

Price

2.12

Target Price

2

Analyst Recom

3

Performance Q

30.86

Relative Volume

0.52

Beta

-2.06

Ticker: SAVA




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04SAVA20.170.0263607
2025-07-07SAVA1.930.170.5763839
2025-07-08SAVA2.080.170.0564335
2025-07-09SAVA2.20.171.1665292
2025-07-10SAVA2.160.180.0266318
2025-07-11SAVA2.140.180.0866530
2025-07-14SAVA2.160.180.2265887
2025-07-15SAVA2.060.180.6166108
2025-07-16SAVA2.070.190.0966460
2025-07-17SAVA2.10.190.6066451
2025-07-18SAVA2.220.190.0966542
2025-07-21SAVA2.310.120.0459959
2025-07-22SAVA2.60.120.1160793
2025-07-23SAVA2.70.120.0264193
2025-07-24SAVA2.530.120.2065162
2025-07-25SAVA2.370.120.4265027
2025-07-28SAVA2.380.120.0363336
2025-07-29SAVA2.210.120.2164427
2025-07-30SAVA2.170.120.1764412
2025-07-31SAVA2.10.120.3264509
2025-08-01SAVA2.120.120.2765107
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04SAVA2.01- - 0.00
2025-07-07SAVA1.93- - 0.00
2025-07-08SAVA2.08- - 0.00
2025-07-09SAVA2.19- - 0.00
2025-07-10SAVA2.16- - 0.00
2025-07-11SAVA2.13- - 0.00
2025-07-14SAVA2.16- - 0.00
2025-07-15SAVA2.06- - 0.00
2025-07-16SAVA2.08- - 0.00
2025-07-17SAVA2.10- - 0.00
2025-07-18SAVA2.22- - 0.00
2025-07-21SAVA2.31- - 0.00
2025-07-22SAVA2.60- - 0.00
2025-07-23SAVA2.70- - 0.00
2025-07-24SAVA2.52- - 0.00
2025-07-25SAVA2.35- - 0.00
2025-07-28SAVA2.39- - 0.00
2025-07-29SAVA2.21- - 0.00
2025-07-30SAVA2.16- - 0.00
2025-07-31SAVA2.10- - 0.00
2025-08-01SAVA2.12- - 0.00
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04SAVA0.00-8.1819.58
2025-07-07SAVA0.00-8.1919.58
2025-07-08SAVA0.00-8.1919.58
2025-07-09SAVA0.00-8.1919.58
2025-07-10SAVA0.00-8.1919.58
2025-07-11SAVA0.00-8.1916.68
2025-07-14SAVA0.00-7.5716.68
2025-07-15SAVA0.00-7.5716.68
2025-07-16SAVA0.00-7.5716.68
2025-07-17SAVA0.00-7.5716.68
2025-07-18SAVA0.00-7.5716.68
2025-07-21SAVA0.00-7.5516.68
2025-07-22SAVA0.00-7.5516.68
2025-07-23SAVA0.00-7.5516.68
2025-07-24SAVA0.00-7.5516.68
2025-07-25SAVA0.00-7.5514.96
2025-07-28SAVA0.00-18.0514.96
2025-07-29SAVA0.00-18.0514.96
2025-07-30SAVA0.00-18.0514.96
2025-07-31SAVA0.00-18.0514.96
2025-08-01SAVA0.00-18.0514.96
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.68

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-18.05

Beta

-2.06

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

8

Growth Score

17

Sentiment Score

3

Actual DrawDown %

98.6

Max Drawdown 5-Year %

-99.1

Target Price

2

P/E

Forward P/E

PEG

P/S

P/B

0.8

P/Free Cash Flow

EPS

-1.51

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.52

Return on Equity vs Sector %

-80.8

Return on Equity vs Industry %

-62.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Cassava Sciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 30
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.
stock quote shares SAVA – Cassava Sciences, Inc. Stock Price stock today
news today SAVA – Cassava Sciences, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch SAVA – Cassava Sciences, Inc. yahoo finance google finance
stock history SAVA – Cassava Sciences, Inc. invest stock market
stock prices SAVA premarket after hours
ticker SAVA fair value insiders trading